Viking Systems' first-quarter 2010 sales up 26%

NewsGuard 100/100 Score

Viking Systems, Inc. (OTCBB:VKNG) today announced financial results for its first quarter ended March 31, 2010. The Company reported a 26% increase in sales to $1,915,073 for the quarter ended March 31, 2010 and a net loss of $295,450 or ($0.01) per share.

Jed Kennedy, Viking Systems' President and Chief Executive Officer, commented, "We are pleased by our solid first quarter results. Our OEM sales continue to demonstrate strong growth while providing a healthy foundation that allows us to continue the development of our Next Generation 3DHD vision system."

Financial Results

Sales. Sales were $1,915,073 for the three months ended March 31, 2010 and $1,521,228 for the three months ended March 31, 2009, representing an increase of 26%. The increase in sales was due to higher demand of the Company's OEM products.

Gross Profit. Gross profit increased 36% for the three months ended March 31, 2010 as compared with the same period in 2009. Gross margin was 26% of sales for the first quarter of 2010 compared with 24% of sales for the first quarter of 2009. The increase in gross margin percentage for 2010 is due to a favorable sales mix of higher margin products as well as higher production volumes resulting in lower per unit manufacturing costs.

Operating Expenses

Operating Expenses.  Viking Systems incurred total operating expenses of $796,420, for the three months ended March 31, 2010 compared with $775,549 for the three months ended March 31, 2009.  Excluding non-cash stock-based compensation expense, total operating expenses for the three months ended March 31, 2010 and 2009 were $708,563 and $663,881, respectively. This represents an increase of $44,682, or 7%, in operating expenses.  This increase in total operating expenses is primarily due to increased research and development related expenses.

Selling and Marketing Expense. Selling and marketing expenses were $206,603 for the three months ended March 31, 2010 and $256,070 for the three months ended March 31, 2009.  This represents a decrease of $49,467 or 19%.  This decrease is primarily due to lower depreciation expense related to demonstration equipment as such equipment became fully depreciated during 2009.

Research and Development Expense.  The Company had research and development expenses of $206,781 for the three months ended March 31, 2010 and $153,165 for the three months ended March 31, 2009, representing an increase of $53,616 or 35%.  The increase in research and development expense occurred primarily due to the development costs associated with our next generation 3D visualization system including the hiring of a Vice President of Research and Development in January 2010.

General and Administrative Expense.  General and administrative expenses include costs for administrative personnel, legal and accounting expenses and various public company expenses. General and administrative expenses were $383,036 for the three months ended March 31, 2010 and $366,314 for the three months ended March 31, 2009, representing an increase of $16,722 or 5%.  This increase was primarily due to increased public company and legal costs. The increase in legal costs included costs associated with filing new patent applications.

Operating loss. As a result of increased sales and higher margins the Company has reduced its operating loss by $111,861. The operating loss was $295,486 for the quarter ended March 31, 2010 compared with $407,347 for the same period in 2009. The operating loss before non-cash charges was $169,359 for the quarter ended March 31, 2010 compared with  a loss of $198,692 for the same period in 2009.

Business Update

Financing

The Company recently announced that it has raised $934,897 by selling an aggregate of 4,398,050 common shares through its previously announced financing facility with Dutchess Opportunity Fund, II, LP.

The Company has previously stated, and again reiterated, that it intends to raise a total of $2 million to $3 million during 2010 to fund the development and launch of its Next Generation 3DHD system, anticipated 2010 operating losses and working capital needs.

Technology

The Company continues to advance towards the release of its Next Generation 3DHD vision system planned for October 2010.  The "Next Gen" product is planned to provide both 2D and 3D viewing options, improved image quality, and a 3DHD flat panel display as an alternative to head mounted displays currently marketed by the Company. The Company continues to strengthen its intellectual property and has filed three provisional patents to date in 2010 with more planned. The Company has demonstrated prototype products at certain industry conferences and completed its preclinical evaluations. The Company believes that feedback from these forums has been extremely positive and has reinforced the Company's evaluation of the market opportunity and expected demand for a high quality surgical 3D vision system.

Jed Kennedy commented, "The feedback from surgeons who had an opportunity to use the system was extremely encouraging. Performing complex minimally invasive procedures with a 3D vision system has the potential not only to improve the quality of care but also to reduce procedure time and therefore cost of procedures."

Selling & Marketing

The Company continues to present its "Next Gen" 3DHD system at medical trade shows worldwide. Recently Sony invited Viking Systems to participate in their three dimensional presentation at "Hospital Build Asia 2010 Exhibition and Congress" in Singapore from May 11-13, 2010.  Viking Systems will provide its 3DHD surgical camera system for use in the Sony booth.  Hospital Build Asia 2010 Exhibition and Congress provides a forum for the healthcare industry and decision-makers from key markets across the region to identify and evaluate the latest in medical device technology as they make critical decisions about how to provide the best and most cost effective healthcare for people in the region.

SOURCE Viking Systems, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
FUJIFILM Healthcare Europe introduces EndoGel training model for endoscopic procedures